These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15314716)

  • 21. [Guidelines for the sociomedical assessment of performance in patients suffering from chronic obstructive lung diseases (COPD) and bronchial asthma. II: Sociomedical assessment of performance, Annex Part B, bibliography see Part I, Gesundheitswesen 2004, 66: 263f].
    Becker E; Horn S; Hussla B; Irle H; Knorr I; Korsukéwitz C; Pottins I; Rohwetter M; Schuhknecht P; Timner K
    Gesundheitswesen; 2004 Jul; 66(7):439-56. PubMed ID: 15314736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B today.
    Safioleas M; Lygidakis NJ; Manti C
    Hepatogastroenterology; 2007 Mar; 54(74):545-8. PubMed ID: 17523319
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinicopathologic features and outcome after liver resection for hepatocellular carcinoma in patients with concurrent versus previous chronic hepatitis B.
    Kubo S; Tanaka H; Shuto T; Takemura S; Yamamoto T; Kanazawa A; Uenishi T; Tanaka S; Hirohashi K; Nishiguchi S; Kinoshita H
    Surg Today; 2005; 35(3):216-22. PubMed ID: 15772792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ministry of Health clinical practice guidelines: Chronic Hepatitis B Infection.
    Chow WC; Chong R; Guan R; Ho KY; Leo YS; Loy KL; Lui HF; Ng HS; Siew WF; Teo EK; Yeo T
    Singapore Med J; 2011 Apr; 52(4):307-11; quiz 312-3. PubMed ID: 21552794
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of chronic hepatitis B and C virus infection in GI practice].
    Hüppe D; Hartmann H
    Dtsch Med Wochenschr; 2008 Jul; 133(30):1572-7. PubMed ID: 18642220
    [No Abstract]   [Full Text] [Related]  

  • 26. [AASLD practice guidelines: chronic hepatitis B].
    Luo SQ; Zhang LX
    Zhonghua Gan Zang Bing Za Zhi; 2007 Jun; 15(6):477-80. PubMed ID: 17594824
    [No Abstract]   [Full Text] [Related]  

  • 27. Selecting appropriate management strategies for chronic hepatitis B: who to treat.
    McMahon BJ
    Am J Gastroenterol; 2006; 101 Suppl 1():S7-12. PubMed ID: 16448451
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Severe acute exacerbation of chronic hepatitis B: a unique presentation of a common disease.
    Wong VW; Chan HL
    J Gastroenterol Hepatol; 2009 Jul; 24(7):1179-86. PubMed ID: 19682192
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diagnosis and therapy in hepatology: hepatitis B and D].
    Somasundaram R; Zeitz M
    Dtsch Med Wochenschr; 2005 Dec; 130 Suppl 5():S210-2. PubMed ID: 16435712
    [No Abstract]   [Full Text] [Related]  

  • 30. [Opinions about the 2008 Asian Pacific Association for the Study of the Liver guidelines for chronic hepatitis B management].
    Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2008 Apr; 16(4):243-6. PubMed ID: 18423138
    [No Abstract]   [Full Text] [Related]  

  • 31. The management of chronic hepatitis B in the immunocompromised patient: recommendations from a single topic meeting.
    Barclay S; Pol S; Mutimer D; Benhamou Y; Mills PR; Hayes PC; Cameron S; Carman W
    J Clin Virol; 2008 Apr; 41(4):243-54. PubMed ID: 18203658
    [No Abstract]   [Full Text] [Related]  

  • 32. Entecavir for treatment of lamivudine-refractory, HBeAg-positive chronic hepatitis B.
    Sherman M; Yurdaydin C; Sollano J; Silva M; Liaw YF; Cianciara J; Boron-Kaczmarska A; Martin P; Goodman Z; Colonno R; Cross A; Denisky G; Kreter B; Hindes R;
    Gastroenterology; 2006 Jun; 130(7):2039-49. PubMed ID: 16762627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk evaluation in action for cardiovascular health.
    Gilski DJ; Borkenhagen B
    Crit Care Nurse; 2005 Feb; 25(1):26-8, 30-7. PubMed ID: 15756731
    [No Abstract]   [Full Text] [Related]  

  • 34. [Analysis of short-term prognosis on patients with chronic severe hepatitis B using the model for end-stage liver disease].
    Zhou J; He WF; Tang XE
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Jul; 19(7):416-8. PubMed ID: 17631710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HBV DNA level--the determinant of clinical spectrum and disease outcome in chronic hepatitis B.
    Kapoor D
    Trop Gastroenterol; 2008; 29(2):59-61. PubMed ID: 18972763
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical significance and evolution of core promoter and precore mutations in HBeAg-positive patients with HBV genotype B and C: a longitudinal study.
    Chen CH; Lee CM; Hung CH; Hu TH; Wang JH; Wang JC; Lu SN; Changchien CS
    Liver Int; 2007 Aug; 27(6):806-15. PubMed ID: 17617124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection.
    McMahon BJ
    Am J Med; 2008 Dec; 121(12 Suppl):S45-52. PubMed ID: 19185074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interpretations of the 2012 Liver consensus statements of Asian Pacific Association on the diagnosis and treatment of hepatitis B virus infection].
    Wang GQ
    Zhonghua Nei Ke Za Zhi; 2012 Oct; 51(10):749-50. PubMed ID: 23290968
    [No Abstract]   [Full Text] [Related]  

  • 39. [Diagnosis and management of chronic hepatitis B].
    Husa P; Plísek S; Sperl J; Urbánek P; Galský J; Hůlek P; Kümpel P; Nemecek V; Volfová M;
    Klin Mikrobiol Infekc Lek; 2008 Feb; 14(1):36-44. PubMed ID: 18459234
    [No Abstract]   [Full Text] [Related]  

  • 40. Navigating patients and caregivers through the course of Alzheimer's disease.
    Aupperle PM
    J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.